Literature DB >> 34090497

Mosquito vector proteins homologous to α1-3 galactosyl transferases of tick vectors in the context of protective immunity against malaria and hypersensitivity to vector bites.

Ranjan Ramasamy1.   

Abstract

BACKGROUND: An epitope, Galα1-3Galβ1-4GlcNAc-R, termed α-gal, is present in glycoconjugates of New World monkeys (platyrrhines) and other mammals but not in hominoids and Old World monkeys (catarrhines). The difference is due to the inactivation of α1-3 galactosyl transferase (α1-3 GT) genes in catarrhines. Natural antibodies to α-gal are therefore developed in catarrhines but not platyrrhines and other mammals. Hypersensitivity reactions are commonly elicited by mosquito and tick vector bites. IgE antibodies against α-gal cause food allergy to red meat in persons who have been exposed to tick bites. Three enzymes synthesising the terminal α1-3-linked galactose in α-gal, that are homologous to mammalian α and β1-4 GTs but not mammalian α1-3 GTs, were recently identified in the tick vector Ixodes scapularis. IgG and IgM antibodies to α-gal are reported to protect against malaria because mosquito-derived sporozoites of malaria parasites express α-gal on their surface. This article explores the possibility that the α-gal in sporozoites are acquired from glycoconjugates synthesised by mosquitoes rather than through de novo synthesis by sporozoites.
METHODS: The presence of proteins homologous to the three identified tick α1-3 GTs and mammalian α1-3 GTs in two important mosquito vectors, Aedes aegypti and Anopheles gambiae, as well as Plasmodium malaria parasites, was investigated by BLASTp analysis to help clarify the source of the α-gal on sporozoite surfaces.
RESULTS: Anopheles gambiae and Ae. aegypti possessed several different proteins homologous to the three I. scapularis proteins with α1-3 GT activity, but not mammalian α1-3 GTs. The putative mosquito α1-3 GTs possessed conserved protein domains characteristic of glycosyl transferases. However, the genus Plasmodium lacked proteins homologous to the three I. scapularis proteins with α1-3 GT activity and mammalian α1-3 GTs.
CONCLUSIONS: The putative α1-3 GTs identified in the two mosquito vectors may synthesise glycoconjugates containing α-gal that can be transferred to sporozoite surfaces before they are inoculated into skin during blood feeding. The findings merit further investigation because of their implications for immunity against malaria, hypersensitivity to mosquito bites, primate evolution, and proposals for immunisation against α-gal.

Entities:  

Keywords:  Antibodies to α-gal; Galactosyl transferases; Hypersensitivity; Immune protection; Malaria; Mosquito vectors; Tick vectors; α-Gal; α-Gal syndrome; α1-3 Galactosyl epitopes

Year:  2021        PMID: 34090497     DOI: 10.1186/s13071-021-04801-7

Source DB:  PubMed          Journal:  Parasit Vectors        ISSN: 1756-3305            Impact factor:   3.876


  2 in total

1.  Evaluation of the importance of antibodies to α-galactosyl epitopes in immunity to malaria.

Authors:  Ranjan Ramasamy
Journal:  J Vector Borne Dis       Date:  2015-12       Impact factor: 1.688

2.  A role for carbohydrate moieties in the immune response to malaria.

Authors:  R Ramasamy; R T Reese
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

  2 in total
  4 in total

1.  An E3 Ubiquitin Ligase Scaffolding Protein Is Proviral during Chikungunya Virus Infection in Aedes aegypti.

Authors:  Sunil Kumar Dubey; Divya Mehta; Sakshi Chaudhary; Abdul Hasan; Sujatha Sunil
Journal:  Microbiol Spectr       Date:  2022-04-18

2.  Exploring the Ecological Implications of Microbiota Diversity in Birds: Natural Barriers Against Avian Malaria.

Authors:  Vaidas Palinauskas; Lourdes Mateos-Hernandez; Alejandra Wu-Chuang; José de la Fuente; Justė Aželytė; Dasiel Obregon; Alejandro Cabezas-Cruz
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 3.  The α-Gal Syndrome and Potential Mechanisms.

Authors:  Patricia Román-Carrasco; Wolfgang Hemmer; Alejandro Cabezas-Cruz; Adnan Hodžić; José de la Fuente; Ines Swoboda
Journal:  Front Allergy       Date:  2021-12-16

Review 4.  Current and Future Strategies for the Diagnosis and Treatment of the Alpha-Gal Syndrome (AGS).

Authors:  Rita Vaz-Rodrigues; Lorena Mazuecos; José de la Fuente
Journal:  J Asthma Allergy       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.